Hot Natural Products & Bioactive Compounds

BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.

Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.

Hot Products from BioCrick

Showing 2505 - 2512 of 9359 hot products

BioCrick hot natural products and bioactive compounds
Catalog No. Product Name
BCC7063 Citalopram hydrobromide
Highly selective and potent 5-HT uptake inhibitor with no effect on noradrenalin or dopamine uptake (IC50 values are 1.8, 8800 and 41000 nM respectively). Has negligible activity at a wide range of receptors.
BCC7064 DuP 697
Potent and selective inhibitor of cyclooxygenase-2 (IC50 values are 10 and 800 nM for COX-2 and COX-1 respectively). Inhibits prostaglandin synthesis and is anti-inflammatory in vivo. Orally active.
BCC7065 SQ 22536
Inhibitor of adenylyl cyclase (IC<sub>50</sub> = 1.4 <span class='symbol'>&mu;</span>M). Inhibits PGE<sub>1</sub>-stimulated increases in cAMP levels in intact human platelets.
BCC7066 MDL 12330A hydrochloride
Inhibitor of adenylyl cyclase. Also inhibits cAMP and cGMP phosphodiesterases, and blocks slow extracellular and store-operated Ca2+ entry into cells.
BCC7067 Ruthenium Red
Blocks Ca2+ uptake and release from mitochondria, and Ca2+ release from ryanodine-sensitive intracellular stores. Also blocks cell membrane-located capsaicin-activated cation channels (IC50 = 14 nM) and voltage-sensitive Ca2+ channels to inhibit neurotransmitter release.
BCC7068 BMY 45778
Non-prostanoid prostacyclin mimetic that acts as a partial agonist at IP1 prostacyclin receptors. Potently inhibits platelet aggregation in vitro (IC50 = 27-35 nM).
BCC7069 N-Arachidonylglycine
Endogenous anandamide-like compound. Lacks affinity for CB<sub>1</sub> receptors (K<sub>i</sub> &gt; 10 <span class='symbol'>&mu;</span>M), VR1 receptors (EC<sub>50</sub> &gt; 10 <span class='symbol'>&mu;</span>M) and anandamide transporters (IC<sub>50</sub> &gt; 50 <span class='symbol'>&mu;</span>M) but causes hot-plate analgesia in mice when given orally, and suppresses tonic inflammatory pain. Also endogenous GlyT2 inhibitor.
BCC7070 O-2093
Inhibitor of anandamide uptake (IC<sub>50</sub> = 17.3 <span class='symbol'>&mu;</span>M) with little or no activity at CB<sub>1</sub>, CB<sub>2</sub>, TRPV1 and FAAH. Intravenous administration inhibits limb spasticity in mice with chronic relapsing experimental allergic encephalomyelitis (CREAE).